Cargando…
Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus disease: Study Protocol Clinical Trial (SPIRIT Compliant)
BACKGROUND: Congenital cytomegalovirus (CMV) disease, a common mother-to-child infection, can lead to neurological sequelae. Some clinical trials have shown that oral valganciclovir (VGCV) can improve hearing and neurodevelopmental impairment in infants with congenital CMV disease. However, VGCV has...
Autores principales: | Morioka, Ichiro, Kakei, Yasumasa, Omori, Takashi, Nozu, Kandai, Fujioka, Kazumichi, Yoshikawa, Tetsushi, Moriuchi, Hiroyuki, Ito, Yoshinori, Oka, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220768/ https://www.ncbi.nlm.nih.gov/pubmed/32332615 http://dx.doi.org/10.1097/MD.0000000000019765 |
Ejemplares similares
-
Oral Valganciclovir Therapy in Infants Aged ≤2 Months with Congenital Cytomegalovirus Disease: A Multicenter, Single-Arm, Open-Label Clinical Trial in Japan
por: Morioka, Ichiro, et al.
Publicado: (2022) -
Correlation of cytomegalovirus viral load between whole blood and plasma of congenital cytomegalovirus infection under valganciclovir treatment
por: Torii, Yuka, et al.
Publicado: (2023) -
Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection
por: Ohyama, Shohei, et al.
Publicado: (2019) -
Application of multiple injections of contrast agent in head and neck CT arteriovenous angiography in children: Study protocol clinical trial (SPIRIT Compliant)
por: Tang, Shilong, et al.
Publicado: (2020) -
Congenital cytomegalovirus infection and the risk of hearing loss in childhood: A PRISMA-compliant meta-analysis
por: Liu, Pei-Hui, et al.
Publicado: (2021)